Related Experiment Video

Updated: Aug 20, 2026

Epithelial Cell Infection Analyses with Shigella
04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

[Antibiotic treatment of Shigella sonnei gastroenteritis]

    Presse Medicale (Paris, France : 1983)
    |December 23, 2004
    PubMed

    Insights

    Antibiotic treatment for Shigella infections is crucial for reducing symptoms and complications. Azithromycin is now the preferred treatment due to increasing resistance to older antibiotics.

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Pharmacology

    Background:

    • Shigella sonnei infections are characterized by diarrhea and fever, with transmission occurring via the fecal-oral route.
    • Increasing resistance to aminopenicillin and cotrimoxazole necessitates updated treatment guidelines.
    • Human populations in close proximity are most at risk for Shigella transmission.

    Purpose of the Study:

    • To outline current antibiotic treatment strategies for Shigella infections.
    • To address the evolving landscape of antibiotic resistance in Shigella sonnei.
    • To provide guidance on the diagnosis and management of Shigella infections.

    Main Methods:

    • Review of current literature and clinical guidelines on Shigella treatment.
    • Analysis of antibiotic resistance patterns for Shigella sonnei.
    • Synthesis of diagnostic and therapeutic recommendations.

    Main Results:

    • Azithromycin is the recommended first-line treatment for Shigella infections.
    • Ceftriaxone is not recommended as a first-line treatment.
    • Quinolones, specifically ciprofloxacin and ofloxacin, are recommended for adults over a 3-day period and as a last resort in other cases.

    Conclusions:

    • Updated treatment protocols are essential due to emerging antibiotic resistance.
    • Prompt diagnosis through fecal culture is critical for effective management.
    • Guidelines for Shigella treatment are available from health authorities like Afssaps.

    More Related Videos

    A High-throughput Shigella-specific Bactericidal Assay06:11

    A High-throughput Shigella-specific Bactericidal Assay

    Published on: February 27, 2019

    Related Concept Videos

    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

    Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

    Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
    Bacterial Gastroenteritis01:18

    Bacterial Gastroenteritis

    Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
    Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

    Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

    Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

    A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...